Analysis of Methicillin Resistant Staphylococcus Aureus (MRSA) Obtained Through the Emergency Department in a Tertiary Care Hospital in Vancouver Canada From 2001-2005

This study is ongoing, but not recruiting participants.

First Received: November 1, 2005 Last Updated: September 24, 2008 History of Changes

Sponsored by:	University of British Columbia
Information provided by:	University of British Columbia
ClinicalTrials.gov Identifier:	NCT00247858

Purpose

To analyze microbiological data from MRSA samples obtained through the emergency department from 2001-2005. There is a strong clinical suspicion that we are now seeing an outbreak of a new strain of MRSA and we plan to better characterize the Vancouver population and complete a chart review to assess specific associated factors.

Condition
Infection With MRSA Bacteria

Study Type:	Observational
Study Design:	Prospective
Official Title:	Analysis of Methicillin Resistant Staphylococcus Aureus (MRSA) Obtained Through the Emergency Department in a Tertiary Care Hospital in Vancouver Canada From 2001-2005

Resource links provided by NLM:

Drug Information available for: Methicillin Methicillin sodium

U.S. FDA Resources

Further study details as provided by University of British Columbia:

Estimated Enrollment:	97
Estimated Study Completion Date:	November 2005

Detailed Description:

Pulse field gel electrophoresis, SCC mec typing, antibiotic susceptibilities, presence of the Panton-Valentine Leukocidin gene will be carried out. Clinical manifestations and associated factors will be assessed via chart review. These include: recent antibiotic use, recent hospitalization, IV drug use, HIV status, number of co-morbidities identified, presence of soft tissue abscess, post operative status, presence of bacteremia, residence in Vancouver's downtown eastside (an area of particularly low socioeconomic status).

Eligibility

Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Patient had a microbiological sample submitted from the emergency department of the study hospital from 2001- 2005 which grew MRSA.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00247858

Locations

Canada, British Columbia
Vancouver General Hospital
Vancouver, British Columbia, Canada

Sponsors and Collaborators

University of British Columbia

Investigators

Principal Investigator:

Steve Reynolds, MD

University of British Columbia

More Information

No publications provided

Responsible Party:	University of British Columbia ( Dr. Steve Reynolds )
Study ID Numbers:	C05-0247
Study First Received:	November 1, 2005
Last Updated:	September 24, 2008
ClinicalTrials.gov Identifier:	NCT00247858 History of Changes
Health Authority:	Canada: Health Canada

Keywords provided by University of British Columbia:

MRSA, USA300, CMRSA-10, CMRSA-6, soft tissue abscesses

Study placed in the following topic categories:

Bacterial Infections
Anti-Infective Agents
Anti-Bacterial Agents
Staphylococcal Infections

Gram-Positive Bacterial Infections
Methicillin
Abscess
Emergencies

Additional relevant MeSH terms:

Bacterial Infections
Anti-Infective Agents
Anti-Bacterial Agents
Staphylococcal Infections
Gram-Positive Bacterial Infections
Disease Attributes

Methicillin
Pathologic Processes
Therapeutic Uses
Emergencies
Infection
Pharmacologic Actions

ClinicalTrials.gov processed this record on September 10, 2009